Figure 2.Construction of a risk model based on five independent ICDRLs prognostic factors. (A, B) Division of BRCA samples into two risk subgroups. (C) PCA analysis of high and low-risk subgroups. (D) Assessment of clinical survival outcomes for risk subgroups of BRCA. (E) Time-dependent ROC curve analysis.
